Company from Moscow created technology production of biotechnological drugs

The capital LLC "SISTEMA-BIOTEKH", based in the profile Mosmedpark complex, developed technology mass release of productions components for modern biotechnological drugs. Molecular biology, genetics and cellular technologies – the main specializations of the enterprise. This time technology, allowing to receive a highly effective producer adalimumaba was created. This antibody which helps to treat rheumatoid arthritis, an illness Krone, ulcer colitis and other autoimmune diseases. Soon the preparations, containing it is substance, will be made to Russian Federation". Development...